Filing metadata

Accession number
0001104659-17-037045
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Jun 01, 2017
Reporting period
May 30, 2017
Description
Insider transaction

Explore SEC Filings Hub